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Risk for Sudden Cardiac Death Associated
With Marathon Running
As an avid runner and occasional marathoner, I was pleased to learn
that the risk of sudden death during or immediately after running a
marathon is very low (1). Unfortunately, I believe that the authors’
assessment of risk relative to other activities is somewhat misleading.
Assuming that there are 200,000,000 U.S. adults at risk for sudden
death, and that there are 500,000 sudden deaths annually, the risk of
sudden death or cardiac arrest as a function of living hours is
approximately 1 death/3,504,000 h. The rate reported by Maron et al.
(1) during or after a marathon, 1 death/215,000 h, is roughly 16-fold
higher than the rate during normal living.
Thus, although the risk of dying suddenly during a marathon is
quite low, it is still 16 times greater than the risk of sudden death
during all other living activities combined.
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Reply
We thank Rich for his comments. We certainly agree, based on our
recently published data (1), that the risk for sudden death directly
associated with long-distance or marathon running is indeed exceed-
ingly low (i.e., ;1 in 50,000). However, calculation of the overall risk
for premature death associated with living can prove to be a rather
complex and difficult undertaking. In our report (1) we chose to
calculate such values directly from U.S. Vital Statistics and the
National Center for Health Statistics for the years 1979, 1990 and 1991
(2). Perhaps this methodology accounts for the differences between
our published values (1) and the estimates offered by Rich in his letter.
BARRY J. MARON, MD, FACC
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Late Potentials in the Thrombolytic Era:
Time for Reevaluation?
We read with interest the report by Karam et al. (1). The authors
reported a decrease in the prevalence of late potentials with mechan-
ical reperfusion compared with thrombolysis after myocardial infarc-
tion. However, the report raises a number of important issues.
Although the significance of late potentials in the early phase
(,48 h) is unclear, El-Sherif et al. (2) found that only late potentials
recorded between days 6 and 30 were associated with arrhythmic
events. In particular, they recommended that “the optimal time
window for obtaining a signal-averaged ECG is between 6 and 14 days
after infarction.” However, the study by El-Sherif et al. predated the
thrombolytic era and excluded patients .79 years old. Although
Karam et al. justify their recording time on this study, they give only
the median time and neglect to give the range. A median recording
time of 11 days suggests that many recordings may have been made
after day 14, at which time late potentials have little prognostic
significance. Furthermore, the authors fail to give any data on arrhyth-
mic events or sudden death in the patients studied.
This leads to a more fundamental issue, which is the unproved role
of late potentials as a predictor of arrhythmic events in a thrombolyzed
cohort. Many of the pioneering studies referenced in the report
predate the thrombolytic era. The widespread use of thrombolysis and
early revascularization have significantly reduced the arrhythmic event
and mortality rates after acute myocardial infarction (3,4). These same
studies (neither of which is referenced) have failed to show a relation
between late potential development and arrhythmic events in a
thrombolyzed patient cohort.
We previously showed (5) that late potentials in the first 7 days
after acute anterior myocardial infarction (after thrombolysis) are
associated with an increase in ventricular volume at 6 weeks. In a
larger study of patients receiving thrombolyic therapy, Hohnloser et al.
(4) also found that late potentials were associated with wall motion
abnormalities. On the basis of our findings, we suggested that the
prognostic value of late potentials in the first week (and particularly on
day 3) may be related to ventricular dilation. Although Karam et al.
performed radionuclide left ventricular angiography in all patients, no
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volume data are presented. Did they examine the relation of late
potentials in the first week to ventricular volume?
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Reply
We thank Zaman et al. for their comments. Regarding the timing of
recording of late potentials, as they pointed out, the study by El-Sherif
et al. (1) predated the thrombolytic era. Other studies have found that
late potentials generally do not disappear over time in patients with
postinfarction sustained ventricular tachycardia and that the delayed
(.30 days) appearance of late potentials is a rather rare phenomenon
(2,3). Late potentials recorded up to 2 years after infarction may thus
retain or even increase their prognostic significance. Therefore, there
is no clear conclusion regarding the optimal timing of recording of late
potentials in the reperfusion era. Indeed, the Task Force Committee of
the European Society of Cardiology, American Heart Association and
American College of Cardiology in establishing standards for analysis
of late potentials has stated that “the optimum time for recording the
high-resolution ECG has not been defined . . . ” (4). In our study, 83%
of the patients underwent recording during the 6- to 30-day period,
which El-Sherif et al. (1) found to be the most closely associated with
arrythmic events. In addition, the difference in the prevalence of late
potentials cannot be ascribed to the difference in the timing of
recording between the three groups that we compared (median of 11
days in all three groups, range 5 to 390 days).
The role of late potentials as a predictor of arrhythmic events in a
thrombolyzed cohort is an important and controversial (5) issue but
was outside the scope of our study. Our patients were selected on the
basis of acute Thombolysis in Myocardial Infarction grade 3 patency of
the infarct-related vessel, and the event rate would be expected to be
very low; it is indeed conceivable that in this specific patient subset
(with patent infarct-related arteries), late potentials lose their predic-
tive value. The hypothesis that the difference in late potentials between
thrombolysis and angioplasty may translate into a difference in ar-
rhythmic events will be tested in a large, randomized study. We wish to
point out that we did reference the study by Honhloser et al. (6)
(reference 45 in our article). Those authors showed that even in the
thrombolysis era, the presence of late potentials is predictive of the
occurrence of arrythmic events, although this index was less helpful
than patency of the infarct-related artery. The best predictive value for
arrhythmias in the postinfarction period was the combination of
infarct-related artery patency, left ventricular ejection fraction and late
potentials (6). Likewise, the study by McClements et al. (7), cited by
Zaman et al. in support of their assumption that there is no relation
between late potentials and arrhythmic events in a thrombolyzed
cohort, found the opposite. In that series of survivors of myocardial
infarction, 68% of whom received thrombolytic agents, the authors
concluded that “the signal averaged ECG and left ventricular ejection
fraction are each independently predictive of arryhthmic events after
myocardial infarction. . . .”
Finally, we did not measure left ventricular volume but only left
ventricular ejection fraction, and we therefore cannot examine the
interesting hypothesis that the prognostic value of late potentials in the
first week is related to left ventricular dilation.
PHILIPPE GABRIEL STEG, MD
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“Prevalence” or “Pretest Likelihood” of
Coronary Artery Disease?
We read with great interest the report of Amanullah et al. (1) on the
diagnostic efficacy of adenosine sestamibi perfusion single-photon
emission computed tomography (SPECT) in women. Detection of
coronary artery disease by noninvasive testing is more difficult in
women than in men, especially in terms of positive predictive values.
One of the causes of this difficulty is the global lower prevalence of
coronary artery disease in women (2,3). The authors report a very high
performance of adenosine sestamibi myocardial perfusion SPECT in
women, and emphasize that these performances are maintained in a
group of women with a low pretest likelihood of coronary artery
disease.
225JACC Vol. 29, No. 1 LETTERS TO THE EDITOR
January 1997:221–8
